Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Intelligent Pills Market Set To Climb From $5.28 Billion In 2026 To $8.65 Billion By 2030
The intelligent pills market has experienced significant expansion recently. It is projected to expand from $4.66 billion in 2025 to $5.29 billion in 2026, at a compound annual growth rate (CAGR) of 13.4%. The increase observed in previous periods is largely due to developments in medical imaging, the demand for gastrointestinal disease diagnosis, the rise of minimally invasive diagnostics, the integration of technology in hospitals, and breakthroughs in wireless sensor innovation.
The intelligent pills market size is projected to experience substantial expansion in the coming years, reaching $8.65 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. This anticipated expansion during the forecast period is driven by factors such as the widening reach of remote healthcare, the advent of AI-enabled diagnostic tools, the evolution of the digital health ecosystem, the increasing necessity for chronic disease monitoring, and advancements in smart medical device innovation. Significant trends shaping the market during this period encompass the increasing utilization of capsule endoscopy technologies, a surge in the adoption of ingestible sensors, the broader deployment of remote patient monitoring applications, the growing need for non-invasive diagnostic instruments, and the incorporation of wireless data transmission into diagnostics.
Get A Free Sample Report With In-Depth Market Insights:
Intelligent Pills Market Demand Drivers: What’s Powering Industry Growth?
The intelligent pills market is anticipated to grow as the number of lifestyle-related disorders increases. These disorders are non-communicable illnesses primarily influenced by an individual’s daily habits, behaviors, and life choices. The rising incidence of lifestyle-related disorders is largely fueled by poor dietary habits, which contribute to conditions like obesity, heart disease, and diabetes. Intelligent pills offer customized treatment for lifestyle-related disorders by enabling real-time health monitoring, providing data-driven insights, improving medication adherence, and optimizing therapeutic outcomes. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, up from 64.0% in 2022 to 2023. Thus, the increasing prevalence of lifestyle-related disorders is a significant driver for the intelligent pills market.
Intelligent Pills Market Segment Outlook: Which Categories Are Growing Fastest?
The intelligent pills market covered in this report is segmented –
1) By Type: Occult GI Bleeding, Chron’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes
2) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
3) By Application: Capsule Endoscopy, Drug Delivery, Patient Monitoring
4) By End-User: Hospital Pharmacy, Clinics, Research Institutes, Home Healthcare
Subsegments:
1) By Occult GI Bleeding: Detection Of Hidden Gastrointestinal Bleeding, Non-Invasive Diagnosis Of Occult Blood Loss
2) By Crohn’s Disease: Monitoring Disease Progression, Assessment Of Intestinal Inflammation
3) By Small Bowel Tumors: Tumor Identification In The Small Intestine, Tumor Monitoring And Diagnosis
4) By Celiac Disease: Detection Of Gluten-Induced Damage In The Intestine, Monitoring Adherence To Gluten-Free Diet
5) By Inherited Polyposis Syndromes: Detection Of Polyps In The Gastrointestinal Tract, Risk Assessment And Monitoring For Genetic Polyposis
Intelligent Pills Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the Intelligent Pills market are prioritizing the utilization of innovative technologies, such as wearable ingestion tracking devices, to improve medication compliance and patient supervision. These wearable ingestion tracking devices are gadgets designed to be worn on the wrist or body, monitoring when patients take their medication to help ensure timely doses, enhance adherence, and provide real-time data to healthcare providers for improved treatment outcomes. For example, in November 2023, etectRx Inc., a US-based digital health company, unveiled the Wrist-Worn Reader, an advanced technology designed to augment the ID-Cap System. This device integrates smoothly with the existing ID-Cap medication monitoring capsule, offering a convenient wrist-worn alternative to the previous necklace-style reader, thereby boosting comfort and ease of use. The Wrist-Worn Reader continuously records ingestion events, provides alerts for missed doses, and supports clinical studies like HIV PrEP trials, consequently enhancing adherence and patient outcomes. Its adaptability to diverse user preferences and lifestyles sets it apart from conventional monitoring solutions.
Intelligent Pills Market Leading Companies And Competitive Benchmarking
Major companies operating in the intelligent pills market are RF Co. Ltd., OMOMED S.A., Shangxian Minimal Invasive Inc., Medtronic Given Imaging (PillCam Division), Shenzhen ANX Robotica, Capsovision Europe GmbH, BDD (Bio-Medical Device Development Ltd.), SmartPill Corporation, ReX Medical, Sensilize Ltd., HQ Inc., JIFU Medical, Chongqing Jinshan Capsule Endoscopy, CapsoVision Asia, NaviCam Medical Systems, IntroMedic Europe, EBS Medical, Check-Cap Imaging, Biora Therapeutics, etectRx Digital Health
View The Full Intelligent Pills Market Report:
Intelligent Pills Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the intelligent pills market in 2025. The regions covered in the intelligent pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model